Update in female reproduction: A life-cycle approach

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2439-2446

  Barbieri, Robert L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANASTROZOLE; ANDROGEN; ANTIANDROGEN; AROMATASE INHIBITOR; CLOMIFENE; CLOMIFENE CITRATE; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN PLUS PROGESTIN; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; FOLLITROPIN; GESTAGEN; GONADORELIN DERIVATIVE; GOSERELIN; HYDROXYPROGESTERONE CAPROATE; LETROZOLE; LEUPRORELIN; MEDROXYPROGESTERONE ACETATE; METFORMIN; NORETHISTERONE; NORETHISTERONE ACETATE; PROGESTERONE; PROGESTERONE RECEPTOR MODULATOR; TESTOSTERONE; VA 2914;

BARIATRIC SURGERY; BLEEDING; BONE DENSITOMETRY; BONE DENSITY; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; COMBINATION CHEMOTHERAPY; CONCEPTION; CONTRACEPTION; CRYOPRESERVATION; DIET; DRUG WITHDRAWAL; DYSLIPIDEMIA; ENDOCRINE FUNCTION; ENDOMETRIOSIS; EPIGENETICS; ESTROGEN THERAPY; EVENING DOSAGE; EXERCISE; FEMALE INFERTILITY; FEMALE REPRODUCTION; GLUCOSE TOLERANCE TEST; HIRSUTISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFERTILITY THERAPY; INSULIN RESISTANCE; LIFE CYCLE; LIFESTYLE MODIFICATION; LOW BIRTH WEIGHT; MATERNAL DISEASE; MATERNAL HYPERGLYCEMIA; MENOPAUSE; MONOTHERAPY; OBESITY; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PELVIS PAIN SYNDROME; PREGNANCY; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SIDE EFFECT; VASOMOTOR DISORDER; VIRILIZATION;

EID: 47549094340     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0752     Document Type: Article

References (54)

1. Barker DJB, Medical Research Council (Great Britain), Environmental Epidemiology Unit 1992 Fetal and infant origins of adult disease: papers. London. British Medical Journal
2. Waterland RA, Jirtle RL 2003 Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23:5293-5300
3. Ibanez L, Ong K, Dunger DB, de Zegher F 2006 Early development of adiposity and insulin resistance after catch-up weight gain in small for gestational age children. J Clin Endocrinol Metab 91:2153-2158
4. Ibanez L, Lopez-Bermejo A, Suarez L, Marcos MV, Diaz M, de Zegher F 2008 March 11 Visceral adiposity without overweight in children born small for gestational age. J Clin Endocrinol Metab 93:2079-2083
5. Hovi P, Andersson S, Eriksson JG, Jarvenpaa AL, Strang-Karlsson S, Makitie O, Kajantie E 2007 Glucose regulation in young adults with very low birth weight. N Engl J Med 356:2053-2063
6. Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F 2008 Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche. J Clin Endocrinol Metab 93:1841-1845
7. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ 2007 Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 30:2287-2292
8. Baker JL, Olsen LW, Sorensen TIA 2007 Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 357:2329-2337
9. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L 2007 Adolescent overweight and future adult coronary heart disease. N Engl J Med 357:2371-2379
10. Heutling D, Schulz H, Nickel I, Kleinstein J, Kaltwasser P, Westphal S, Mittermayer F, Wolzt M, Kryzanowska K, Randeva H, Schernthaner G, Lehnert H2008 Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J Clin Endocrinol Metab 93:82-90
11. Valkenburg O, Steegers-Theunissen RP, Smedts HP, Dallinga-Thie GM, Fauser BC, Westerveld EH, Laven JS 2008 A more atherogenic serum lipoprotein profile is present inwomenwith polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab 93:470-476
12. Shroff R, Kerchner A, Maifeld M, Van Beek EJ, Jagasia D, Dokras A 2007 Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab 92:4609-4614
13. Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ 2006 Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:1741-1747
14. Tasali E, Van Cauter E, Ehrmann DA 2006 Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 91:36-42
15. Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE 2007 Glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 92:4546-4556
16. Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfeld, RL, Shapiro J, Montori VM, Swigio BA 2008 Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1105-1120
17. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2008 Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89:505-522
18. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER 2007 Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356:551-566
19. Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F 2006 Effect of clomiphene citrate plus metformin and clomiphene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomized double blind clinical trial. BMJ 332:1485
20. Begum MR, Ferdous J, Begum A, Quadir E 2008 January 3 Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertil Steril [Epub ahead of print]
21. Badawy A, Aal IA, Abulatta M 2008 December 29 Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial. Fertil Steril [Epub ahead of print]
22. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M 2008 Adjustable gastric banding and conventional therapy for type 2 diabetes. A randomized controlled trial. JAMA 299:316-323
23. Eid GM, Cottam DR, Velcu LM, Mattar SG, Korytkowski MT, Gosman G, Hindi P, Schauer PR 2005 Effective treatment of polycystic ovary syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis 1:77-80
24. Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, Sancho J, San Millan JL 2005 The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 90:6364-6369
25. Wax JR, Pinette MG, Cartin A, Blackstone J 2007 Female reproductive issues following bariatric surgery. Obstet Gynecol Surv 9:595-604
26. Chabbert-Buffet N, Pintiaux-Kairis A, Bouchard P 2007 Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo controlled trial. J Clin Endocrinol Metab 92:3582-3589
27. Legro RS, Pauli JG, Kunselman AR, Meadows JW, Kesner JS, Zaino RJ, Demers LM, Gnatuk CL, Dodsen WC 2008 Effects of continuous versus cyclical oral contraception: a randomized controlled trial. J Clin Endocrinol Metab 93:420-429
28. Barbieri RL, Petro Z, Canick JA, Ryan KJ 1983 Aromatization of norethindrone to ethinyl estradiol by human placental microsomes. J Clin Endocrinol Metab 55:299-303
29. Chu MC, Zhang X, Gentzschein E, Stanczyk FZ, Lobo RA 2007 Formation of ethinyl estradiol inwomenduring treatment with norethindrone acetate. J Clin Endocrinol Metab 92:2205-2207
30. Utsunomiya H, Cheng YH, Lin Z, Reierstad S, Yin P, Attar E, Xue Q, Imir G, Thung S, Trukhacheva E, Suzuki T, Sasano H, Kim JJ, Yaegashi N, Bulun SE 2008 Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. Mol Endocrinol 22:904-914
31. Remorgida V, Abbamonte LH, Ragni N, Fulcheri E, Ferrero S 2007 Letrozole and desogestrel-only contraceptive pill for the treatment of stage IV endometriosis. Aust N Z J Obstet Gynaecol 47:222-225
32. Attar E, Bulun SE 2006 Aromatase inhibitors: the next generation of therapeutics for endometriosis. Fertil Steril 85:1307-1318
33. Soysal S, Soysal ME, Ozer S, Gul N, Gezgin T 2004 The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 19:160-167
34. Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A 2006 Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril 85:314-325
35. Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa T 2007 December 26 Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril [Epub ahead of print]
36. American College of Obstetricians and Gynecologists 2002 ACOG Practice Bulletin. Clinical management guidelines for obstetrician- gynecologists. Number 37, August 2002. (Replaces Practice Bulletin Number 32, November 2001). Thyroid disease in pregnancy. Obstet Gynecol 100:387-396
37. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A 2007 Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92(Suppl):S1-S47
38. Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchinson S, Bilous R 2007 Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 92:203-207
39. Brent GA 2007 Diagnosing thyroid dysfunction in pregnant women: is case finding enough. J Clin Endocrinol Metab 92:39-41
40. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH 2007 Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 357:462-469
41. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM 2003 Prevention of recurrent preterm delivery by 17-hydroxyprogesterone caproate. N Engl J Med 348:2379-2385
42. Jain JK, Paulson RJ 2006 Oocyte cryopreservation. Fertil Steril 86:1037-1046
43. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K, American Society of Clinical Oncology 2006 American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol [Erratum (2006) 24:5790] 24:2917-2931
44. Oktay K, Cil AP, Bang H 2006 Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 86:70-80
45. Grewal SS, Kahn JP, MacMillan ML, Ramsay NK, Wagner JE 2004 Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 103:1147-1151
46. Van de Velde H, Georgiou I, De Rycke M, Schots R, Sermon K, Lissens W, Devroey P, Van Steirteghem A, Liebaers I 2004 Novel universal approach for preimplantation genetic diagnosis of beta-thalassanemia in combination with HLA matching of embryos. Hum Reprod 19:700-708
47. Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, Korach KS, Shaul PW, Mangelsdorf DJ 2007 27-hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med 13:1185-1192
48. Heiss G, Wallace R, Anderson GL, Aragaki MS, Beresford SAA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML 2008 Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 299:1036-1045
49. Roussow JE, Prentice RL, Manson JE, Wu LL, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML 2007 Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause JAMA 297:1465-1477
50. Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH, Cochrane BB, Hunt JR, Ludlam SE, Pettinger MB, Gass M, Margolis KL, Nathan L, Ockene JK, Prentice RL, Robbins J, Stefanick ML 2007 Estrogen therapy and coronary-artery calcification. N Engl J Med 356:2591-2602
51. Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Levesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY 2007 Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 115:840-845
52. Fournier A, Berrino F, Clavel-Chapelon F 2008 Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 107:103-111
53. Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N 2006 Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 91:3697-3710
54. Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ 2007 Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 92:3040-3043